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1. Introduction 
1.1 Imaging of nasopharyngeal carcinoma 
Nasopharyngeal carcinoma (NPC) is the most common neoplasm to affect the nasopharynx 
(NP). Arising from the epithelial lining of the nasopharyngeal mucosa, NPC is distinct from 
squamous cell carcinoma affecting other sites of the pharyngeal space. NPC typically 
originates in the lateral wall of the nasopharynx and is noted as a locally aggressive 
neoplasm with a high incidence of metastases to cervical lymph nodes. The primary tumour 
can extend within the nasopharynx and/or to the base of the skull, palate, nasal cavity or 
oropharynx. Distant metastases can arise in bone, lung, mediastinum, and, more rarely, the 
liver (Brennan, 2006). 
The etiology of NPC is multifactorial and involves many environmental and genetic risk 
factors (Henderson et al., 1976). In particular, diets high in salt-preserved foods – such as 
salted fish, meat, eggs, fruits and vegetables in the Southern Asian diet – have been 
identified as possible causative factors acting through the carcinogen, N-
nitrosodimethylamine (Yu et al., 1988). In contrast, frequent consumption of fresh fruits 
and/or vegetables – especially during childhood – is associated with a lower risk of NPC. In 
addition, studies have indicated a causal role for the Epstein-Barr virus (EBV) in the 
development of NPC (Chang & Adami, 2006). EBV is a DNA virus responsible for infectious 
mononucleosis, post-transplantation lymphoproliferative disease, and Burkitt’s lymphoma. 
Elevated IgG and IgA antibody titres against viral capsid antigen, early antigen, and latent 
viral nuclear antigens have been noted in NPC patients. Furthermore, these antibodies have 
been shown to precede tumour development by several years. EBV DNA, RNA, and gene 
products have also been detected in tumour cells (Chang & Adami, 2006). EBV serology is 
currently used as a screening tool for high-risk populations in southern China (Glastonbury, 
2007). Certain genetic haplotypes – HLA A2, Bsn 2, B46, and B58 – are also associated with 
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increased risk (Ren & Chan, 1996). Other exposures implicated in NPC include cigarette 
smoking, other smoke, and occupational exposures including wood dust and industrial heat 
(Yu et al., 2010). 
2. Epidemiology of NPC 
NPC is a rare malignancy that exhibits a distinct ethnic and geographic variation (Chang & 
Adami, 2006). While in most regions of the world, age standardized incidence rates for both 
males and females are <1 per 100,000 person-years (Chang & Adami, 2006; Chong, 2006)), 
higher rates are observed in a few well-defined populations. Studies have demonstrated 
intermediate incidence rates in several indigenous populations in Southeast Asia, the Arctic, 
and the Middle East/North Africa (ranging from 0.5 to 31.5 per 100,000 person-years in 
males and 0.1 to 11.8 person-years in females) (Chang & Adami, 2006; Parkin et al., 2002), 
and endemic rates in the natives of southern China reaching 20-30 per 100,000 person-years 
and 15-20 per 100,000 person-years amongst males and females, respectively, in the province 
of Guangdong (Ho, 1978; Yoshizaki et al., 2011). In addition, within geographic regions, a 
distinct ethnic variation also exists. For example, in the US, rates are highest amongst 
Chinese Americans, followed by Filipino Americans, Japanese Americans, Blacks, 
Hispanics, and finally Caucasians (Burt et al., 1992). 
Globally, there are more than 80,000 incident cases and 50,000 deaths annually due to NPC 
(Parkin et al., 2005). NPC shows a male predilection of 2-3:1 (Parkin et al., 2002). In low risk 
populations, incidence increases with age, while in high risk populations, incidence peaks in 
the 6th decade of life and declines thereafter. NPC is rare in pediatric populations. Thus, the 
highest incidence rates are observed in middle-aged men (Chang & Adami, 2006). 
3. Histopathology of NPC 
Three histologic subtypes are recognized by the World Health Organization (WHO) 
classification system: 
 Type 1 – squamous cell carcinoma; typically found in older adult populations 
 Type 1 is further subdivided into poorly, moderately, and well-differentiated 
 Type 2 – non-keratinizing carcinoma 
 Type 3 – undifferentiated or poorly differentiated carcinoma, including 
lymphoepithelioma and anaplastic variants; comprises most cases of childhood and 
adolescent NPC 
In contrast to Type 1, Type 2 and 3 are associated with elevated EBV titres. In addition, Type 
2 and 3 may also be accompanied by lymphoepithelioma, which is an inflammatory 
infiltrate of lymphocytes, plasma cells, and eosinophils. Histopathologic typing has 
prognostic significance, as Type 2 and Type 3 exhibit a more favourable prognosis and 
greater radiosensitivity than Type 1. Risk factors for Type 1 include cigarette smoke and 
ethanol consumption, whereas Type 2 and 3 are the endemic forms (Brennan, 2006). 
In NPC, two histological patterns may be recognized: (1) the Regaud type which is a well-
defined collection of epithelial cells surrounded by lymphocytes and connective tissue, and 
(2) the Schmincke type, which appears as diffuse tumours intermingled with inflammatory 
cells (Brennan, 2006). 
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4. Presentation of NPC 
While some patients are asymptomatic, 50% to 70% of patients initially present with cervical 
lymphadenopathy in the form of a neck mass and are diagnosed by lymph node biopsy 
(Glastonbury, 2007). Symptoms at presentation may include trismus, pain, otitis media due 
to Eustachian tube dysfunction, nasal regurgitation due to paresis of the soft palate, and 
hearing loss. Depending on the degree of local infiltration, patients may also suffer from 
cranial nerve dysfunction and headache. Cranial nerve neuropathies (most often CN5 and 
CN6) are an indication of skull base infiltration. Larger growths may also produce nasal 
obstruction or bleeding and a "nasal twang". Metastatic spread may result in bone pain or 
organ dysfunction. Rarely, a paraneoplastic syndrome of osteoarthropathy may occur with 
widespread disease. 
5. Role of imaging in the management of NPC 
All stages of NPC patient management, from diagnosis and staging to treatment and follow-
up, involve imaging. On presentation, a full diagnostic work-up for NPC involves a physical 
examination (including neurological examination of the cranial nerves), laboratory testing 
(including a complete blood count, liver function tests, and alkaline phosphate levels), an 
endoscopic-guided biopsy, as well as imaging studies. Since 6% of NPC is submucosal and 
cannot been seen on endoscopy (King et al., 2006), cross-sectional imaging studies, such as 
magnetic resonance imaging (MRI) or computed tomography (CT), are required to help 
confirm the diagnosis, as well as accurately demarcate the exact limits of pharyngeal wall 
involvement and tumour invasion into surrounding structures. Currently, MRI and CT are 
not routinely used for screening purposes; however, the radiologist should consider NPC 
whenever head and neck imaging is obtained, especially in high-risk patients – such as those 
of Asian descent – being evaluated for otitis media or with incidental findings of middle ear 
opacification. 
Early findings of NPC on imaging include asymmetry of the nasopharynx and an obstructed 
Eustachian tube (ET) (Figure 1) (Glastonbury, 2007). Most NPC masses originate in the fossa 
of Rosenmuller, otherwise known as the lateral pharyngeal recess. Furthermore, 
involvement of the lateral pharyngeal recess may cause dysfunction of the ET – either 
directly or indirectly by infiltrating the surrounding musculature – leading to stasis of 
middle ear secretions and unilateral hearing loss (Figure 2). In cases of head and neck 
imaging for neck masses of “unknown primary,” careful attention should be paid to the 
possibility of NPC since cervical lymphadenopathy is the most common presentation. 
Like other neoplasms, a mainstay in NPC treatment is staging. Staging contributes 
information regarding prognosis and helps guide treatment planning, facilitate stratification 
of treatment, and coordinate clinical studies (Mao et al., 2009; Yu et al., 2010). While in the 
past, CT was preferred, MRI is currently the imaging modality of choice for NPC staging 
using the American Joint Committee on Cancer (AJCC) tumour, node, metastasis (TNM) 
staging system (King et al., 1999; Liang, 2009; Ng et al., 1997). CT still has a role in the 
assessment of bony skull base involvement (Olmi, 1995), but MRI is considered superior to 
CT for assessing primary tumour invasion into surrounding soft tissue and bony structures, 
pharyngobasilar fascia invasion, invasion into the sinus of Morgagni, skull base invasion, as 
well as cavernous sinus extension and perineural disease (Liao et al., 2008; Sakata, 1999).  
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Fig. 1. Axial T2 weighted image shows a mass filling the left fossa of Rosenmuller (*).  
 
Fig. 2. Axial T2 weighted image shows a right sided NPC that is resulting in right 
Eustachian tube dysfunction and fluid build up in the right mastoid.  
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MRI is also more reliable for differentiating between the primary tumor and 
retropharyngeal adenopathy (Chang, 2005; Chong, 1996; Chung, 2004; King, 2000). For 
patients with clinical or biochemical evidence of advanced disease, additional investigations 
– including bone scintigraphy, chest x-ray, CT of thorax, abdomen, and pelvis, and/or 
fluorodeoxyglucose (FDG)-positron emission tomography (PET)-CT imaging – may be 
indicated (Caglar, 2003; Chen et al., 2006; Chiesa & De Paoli, 2001; Chua et al., 2009; 
Comoretto et al., 2008; Lee, 1992). 
The mainstay of treatment in NPC is radiation therapy (RT) with the addition of concurrent 
and/or adjuvant chemotherapy reserved for higher stages of disease. Surgical salvage 
(nasopharyngectomy) has also been used in cases of recurrent disease (Yu et al., 2010). The 
goal of treatment is to be curative. To be effective, RT must target the primary lesion as well 
as any associated neck adenopathy. Thus, cross-sectional imaging, in particular MRI, is 
needed to determine areas of disease infiltration. NPC has been shown to spread in a step-
wise pattern along privileged pathways, such as the neuroforamina (Liang et al., 2009). In 
addition, involvement of critical structures located near the NP – including the cavernous 
sinus, pituitary gland, orbit and brainstem – must be evaluated to guide appropriate 
treatment and to spare these structures of the radiation dose if they are clear of disease (Yu 
et al., 2010). In the case of intensity-modulated RT (IMRT), CT is also required to correctly 
calculate dose based on absorption rates (Glastonbury, 2007). 
Follow-up evaluation involves a baseline imaging study that is typically performed 2 to 3 
months after completion of radiation treatment, followed by imaging every 3 to 6 months 
for the first 2 post-treatment years (Glastonbury, 2007). Any soft tissue signal abnormalities 
on MRI in the nasopharynx, deep face, or skull base should remain stable over this period or 
show further reduction in volume. Recurrent disease is seen as any increase in the bulk of 
abnormal signal from baseline imaging. Most recurrences, local or systemic, occur within 
the first 2 years after treatment (Glastonbury, 2007). Of patients with recurrences, 10% to 
20% may be curable with additional treatment (Glastonbury, 2007). After 2 years without 
evidence of recurrence, the imaging interval is typically extended to every 6 to 12 months. 
Although not yet the mainstay of treatment, one meta-analysis demonstrated that FDG-
PET/CT is more sensitive and specific than CT and MRI for the diagnosis of local residual 
or recurrent NPC (Liu et al., 2007). 
5.1 MRI technique 
The staging MRI protocol for NPC varies from center to center. In general, the images 
should cover the area from above the frontal sinuses to the thoracic inlet on axial studies 
and from the tip of the nose to the fourth ventricle on coronal sequences. At our institution, 
axial and coronal T1- and T2-weighted images, as well as a sagittal T1 or T2 fat saturation 
series covering the entire head and neck are obtained. A head and neck imaging coil is 
routinely used for both the 1.5T and 3.0T MRI scanners. The axial, coronal and sagittal T1 
series are performed using a T1-FLAIR technique. Postgadolinium-enhanced axial images 
with fat saturation and coronal images without fat saturation are also acquired using a 
conventional spin echo T1 technique. Lau et al. found that the axial precontrast and 
postcontrast series were the most informative MRI sequences for evaluating primary 
tumour extension and achieved approximately 100% diagnostic accuracy in T-staging of 
NPC (Lau et al., 2004). We find that axial and coronal noncontrast T1-weighted images are 
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the best for providing detailed views of the local NP anatomy and surrounding structures, 
whereas postcontrast images allow for accurate assessment of perineural disease along 
major nerves, such as the maxillary and mandibular divisions of the trigeminal nerve, as 
well as the cavernous sinus (Yu et al., 2010).  
5.2 Comparison of imaging methods 
 
 MRI CT  PET/CT 
Strengths Superior to CT and 
PET/CT for assessing 
primary tumour 
invasion into 
surrounding soft tissue
and boney structures, 
pharyngobasilar fascia 
invasion, invasion into 
the sinus of Morgagni, 
skull base invasion, 
intracranial invasion, as
well as cavernous sinus
extension and 
perineural disease (Liao 
et al., 2008; Ng et al., 
2009 Sakata et al., 1999) 
 
Superior to CT and 
PET/CT for evaluating
retropharyngeal 
adenopathy 
 
No exposure to 
ionizing radiation 
Relatively 
inexpensive 
 
Rapid image 
acquisition time 
 
Widely available 
Superior to MRI and CT for 
assessing lymph node 
metastasis, especially 
cervical nodal metastases, 
and distant metastases, 
especially occult metastatic 
disease (i.e., N- and M-
staging of NPC) (Comoretto 
et al., 2008; King & Bhatia, 
2010; King et al., 2008; Lin et 
al., 2008; Ng et al., 2009, 
Wang et al., 2007) 
 
Screens the entire patient 
for local recurrence, lymph 
node metastases and distant 
metastases during a single 
whole-body examination 
using a single injection of 
FDG 
 
Significantly better 
sensitivity and specificity 
compared to CT and MRI 
for diagnosis of local 
residual or recurrent 
nasopharyngealcarcinoma 
(Liu et al., 2007) 
Weaknesses 
 
Expensive 
 
Long image acquisition 
times compared to CT 
 
Less readily available 
compared to CT not 
always reliable in 
distinguishing between 
enhancing residual 
Less accurate than 
MRI and PET/CT for
evaluating tumour 
invasion into 
surrounding tissues 
(Ng et al., 2009) 
 
Exposure to ionizing
radiation 
 
Accessibility issues (in some 
regions) 
 
Expensive 
 
Exposure to ionizing 
radiation 
 
Compared to MRI, PET/CT 
undermaps the 
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disease versus 
posttherapy changes 
due to treatment-
related edema, fibrosis, 
inflammation, and 
scarring (Comoretto et 
al., 2008) 
Treatment-related 
edema, fibrosis, 
inflammation, and 
scarring limit ability 
to diagnose residual 
or recurrent disease 
involvement of the 
nasopharynx, skull base, 
intracranial disease, 
perineural spread, 
parapharyngeal space, and 
brain (due to high FDG 
uptake by the brain) 
(Comoretto et al., 2008; King 
et al., 2008; Ng et al., 2009) 
 
Inferior to MRI for 
detecting retropharyngeal 
lymph node metastases (Ng 
et al., 2009; Ng et al., 2010, 
Su et al., 2006)  
 
False-positive and false-
negative related to 
inflammatory hyperplastic 
nodes, nodes with large 
areas of necrosis, small 
nodes that are beyond the 
spatial resolution limits of 
PET (Ng et al., 2009; Zhang 
et al., 2006) 
 
6. Anatomy of the nasopharynx 
The nasopharynx is at the superior and posterior aspect of the aerodigestive tract. The 
nasopharyngeal mucosa is lined with squamous epithelium and surrounded by a muscular 
and fascial sling consisting of the superior constrictor muscle and the buccopharyngeal 
fascia derived from the middle layer of the deep cervical fascia. The space has three walls 
and a roof. It opens anteriorly to the posterior nasal cavity via the posterior nasal choanae, 
and inferiorly into the oropharynx at the level of the hard palate. On imaging, the C1/2 
junction is also an accepted marker between the nasopharynx and oropharynx (Dubrulle et 
al., 2007). The roof of the nasopharynx abuts the sphenoid sinus floor, and slopes 
posteroinferiorly along the clivus/basiocciput to the upper cervical vertebrae. Remains of 
adenoid tissue may persist into adulthood and exist as tags in the roof of the nasopharynx. 
The pharyngobasilar fascia (PBF), a tough aponeurosis connecting the superior constrictor 
muscles to the skull base, is perhaps the most important structure of the nasopharynx. The 
tough fibers of the pharyngobasilar fascia create a framework that determines the 
configuration of the nasopharynx and the support by which the entire pharynx hangs from 
the skull base (Dillon et al., 1984). The parallel lateral walls of the pharyngobasilar fascia 
extend from the posterior margin of the medial pterygoid plate anteriorly to the occipital 
pharyngeal tuber and prevertebral muscles posteriorly. The foramen lacerum, which is 
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within the confines of the pharyngobasilar fascia, is a fibrocartilaginous structure that forms 
part of the floor of the horizontal carotid canal and roof of the nasopharynx. It provides a 
route for nasopharyngeal tumors to access the cavernous sinus and intracranial cavity. The 
pharyngobasilar fascia is a fibrous structure and occasionally can be seen as a thin dark line 
on T2-weighted axial MR images, deep to the submucosal tissues of the nasopharynx 
(Figure 3).  
 
 
 
 
Fig. 3. Axial T2 weighted image at the level of the nasopharynx. The arrow shows the 
pharyngobasilar fascia on the left side. 
The paired Eustachian tubes, along with the medial fibers of the levator veli palatini muscle 
pass into the nasopharynx via the sinus of Morgagni, a posterolateral defect in the 
pharyngobasilar fascia. The opening of the Eustachian tube is anterior (on axial images) and 
inferior (on coronal images) to the torus tubarius, the distal cartilaginous end of the 
eustachian tube that forms a mucosal-lined structure projecting into the lumen of the 
nasopharynx from the superior aspect of the posterior lateral nasopharyngeal walls. The 
fossa of Rosenmüller, otherwise known as the lateral pharyngeal recess, is posterior (on 
axial images) and superior (on coronal images) to the torus tubarius. The fossa of 
Rosenmüller is the most common site of origin of NPC (Goh & Lim, 2009) (Figure 4). 
However, asymmetry of the lateral pharyngeal recesses is a common and normal incidental 
finding, and should not be mistaken as tumours. 
Lateral to the nasopharynx is the parapharyngeal space (PPS), a fibrofatty space which 
separates the nasopharynx from the masticator space (Figure 4). Involvement of the 
parapharyngeal fat serves as an important marker of tumour infiltration used in staging. 
The posterolateral boundary of the nasopharynx consists of the carotid space (post-styloid 
parapharyngeal space), which is located posterior to the parapharyngeal space. Located 
posterior to the nasopharynx, between the nasopharyngeal mucosal space and the 
prevertebral muscles, is the retropharyngeal space, a potential space that contains the 
medial and lateral retropharyngeal lymph nodes. The lateral retropharyngeal nodes, also 
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known as the nodes of Röuviere, are the first nodes in the lymphatic drainage of the 
nasopharynx and, along with the cervical Level II nodes, are reported to be the most 
common site of nodal metastases (Wang et al., 2009). The lateral retropharyngeal lymph 
nodes can be identified on MRI from the skull base to the level of C3 (King & Bhatia, 2010). 
The medial retropharyngeal nodes do not form a discrete nodal chain, and thus, are less 
often visible on imaging. 
 
 
Fig. 4. Axial T1 image shows the torus tubarius (*). The solid arrow points to the opening of 
the Eustachian tube. Dashed arrow is the fossa of Rosenmuller. The dashed area shows the 
fat in the left prestyloid parapharyngeal space. 
Other important structures include the foramen rotundum and pterygoid (or Vidian) canal, 
which communicate with the pterygopalatine fossa and are potential routes of tumour 
spread.  
7. Staging of NPC 
After the initial diagnosis of NPC is made on history, physical examination, and biopsy, 
cross-sectional imaging is required for cancer staging. Currently, the 7th edition of the 
International Union Against Cancer (UICC) and American Joint Committee on Cancer 
(AJCC) TMN staging system is used, which was recently revised and released on 1 January 
2010. As previously described, most cases of NPC originate in the lateral pharyngeal recess 
and spread submucosally with early infiltration into deeper neck spaces. NPC tends to have 
well-defined patterns of spread. 
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Box 1. 
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7.1 T1 NPC 
Stage T1 refers to disease that is localized to the nasopharynx, as well as disease that has 
extended inferiorly into the oropharynx or anteriorly into the nasal cavity (Lee,2004; Liu et 
al., 2008; Yu et al., 2010). Disease that is isolated to the NP is described as being superficial to 
the pharyngobasilar fascia (PBF). In this case, there is no evidence of tumour breaching or 
crossing the PBF barrier, which occasionally can be identified on T2-weighted studies as a 
thin dark curvilinear line running from the medial pterygoid plate laterally and following 
the contour of the longus musculature along the back wall of the NP (Figure 3). The tumour 
appears as a hypointense to isointense mass on T1-weighted imaging that enhances to a 
lesser degree than normal mucosa (Chin et al., 2003). 
Oropharyngeal extension is readily noted on coronal or sagittal MR imaging as tumour that 
has extended inferiorly past the plane of palate (Figure 5). On axial sections, the oropharynx 
is considered involved when tumour is seen inferior to the C1/C2 junction.  
 
Fig. 5. Axial image of a patient with NPC that shows disease that has extended down to the 
level of the right oropharynx. 
In addition, stage T1 disease comprises anterior extension past the plane of the posterior 
choana into the nasal cavity (Figure 6). From the nasal cavity, NPC can invade through the 
sphenopalatine foramen into the pterygopalatine fossa (stage T3 disease), resulting in 
obliteration of the normal fat content in this fossa (Figure 7). Direct extension from the nasal 
cavity is the most common route of NPC invasion into the pterygopalatine fossa, followed 
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by extension from the ethmoid and/or sphenoid sinuses. The significance of 
pterygopalatine fossa involvement is described later (T3 NPC). 
 
Fig. 6. NPC which has extended beyond the plane of the posterior choana (dashed line) into 
the nasal cavity. 
 
Fig. 7. Axial T1 weighted image shows abnormal soft tissue filling the right and left 
pterygopalatine fossae (*). 
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7.2 T2 NPC 
Disease that has spread beyond the PBF and infiltrated posterolaterally into the 
parapharyngeal space (PPS) is considered stage T2. This can lead to compression of the 
Eustachian tube, resulting in middle ear and mastoid effusion (King & Bhatia, 2010). PPS 
invasion is associated with worse disease control and survival rates, as well as increased rate 
of distant metastases compared to stage T1 (Cheng et al., 2005; Chua et al., 1996; Ho et al., 
2008; Teo et al., 1996). On imaging, key components of the PPS include the tensor veli 
palatini and levator palatine muscles. PPS involvement is recognized as a disruption or 
attenuation of the PBF, infiltration of the tensor veli palatini, or breach of the 
intrapharyngeal portion of the levator veli palatini muscle.  
Infiltration of the fatty component of the PPS is visible on T1-weighted imaging as an 
intermediate signal mass invading into the hyperintense fat of the PPS (Figure 8). As the 
disease progresses, the full thickness of the intrapharyngeal portion of the levator veli 
muscle and the tensor veli palatini muscle (appearing as a thin strip of muscle just lateral to 
the levator veli palatini) may also become involved, followed by infiltration of the normally 
pristine fat of the prestyloid PPS, which is located deep to the tensor muscle. With further 
posterolateral spread, the poststyloid PPS structures, such as the carotid sheath, also become 
vulnerable to disease (Figure 9). 
 
 
 
 
 
Fig. 8. Axial T2 weighted images shows a carcinoma that has infiltrated lateral to the tensor 
and levator veli palatini. Solid arrow shows normal tensor veli palatini on the right. Dashed 
arrow shows the abnormal left levator muscle which is being displaced and the presence of 
tumor lateral to it. 
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Fig. 9. Axial T1 image shows a large right sided NPC that has extended to encase the right 
internal carotid artery (arrow). 
7.3 T3 NPC 
Stage T3 disease is characterized by involvement of the paranasal sinuses and/or the central 
skull-base structures. Skull base invasion is seen in up to 60% of NPC patients at diagnosis 
(King et al., 1999; Roh et al., 2004), with the most common sites of involvement being the 
clivus, pterygoid bones, body of the sphenoid bone, and apices of the petrous temporal 
bones (King & Bhatia, 2010). In addition, the number of sites involved within the skull base 
may have prognostic significance (Lu et al., 2004). Assessment of the skull base should focus 
on five key regions: clivus, right pterygoid base, left pterygoid base, right petrous apex, and 
left petrous apex (King & Bhatia, 2010). On axial T1-weighted MR sequences, bony skull 
base disease is detected as a loss of the hyperintense signal, which is characteristic of normal 
fatty yellow bone marrow. It is replaced with an intermediate signal indicative of either 
bony reaction or actual invasion. NPC commonly invades posteriorly into the clivus (Figure 
10). Although normal clival marrow may appear heterogeneous on T1-weighted images, it 
should still appear more intense than the pons (Goh & Lim, 2009). In addition, up to 25% of 
patients have tumour spread superiorly into the floor of the sphenoid sinus, often extending 
up into the sphenoid sinus cavity (Chong & Fan, 1993; Goh & Lim, 2009) (Figure 11). The 
body of the sphenoid is more difficult to assess and may be best studied on coronal images 
(King & Bhatia, 2010). The sphenoid wings and upper cervical spine should also be assessed. 
CT scans may also have a role in detecting the presence of cortical erosion and bony 
sclerosis, which reflects reactive changes due to tumour invasion. It is important, however, 
to note that sclerosis is a non-specific sign that may arise from adjacent sinus disease, 
particularly in the sinus margins and the pterygoids.  
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Fig. 10. 10A is a sagittal T1 image that shows NPC invasion into the clivus. There is a loss of 
the inferior cortical margin of the clivus. The clivus is also of uniform lower signal that 
reflects sclerotic change. 10B is as coronal T1 image in another patient that shows NPC 
infiltration into the left aspect of the clivus (arrow). 
 
Fig. 11. Coronal T2 (left) and post gadolinium enhanced T1 (right) weighted images show 
superior extension of NPC through the floor of the sphenoid sinus (arrows). 
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Next, the skull base foramina and fissures – which include the foramen rotundum (V2 
nerve), the vidian canal (vidian nerve), the foramen ovale (V3 nerve), and foramen lacerum 
– should be examined. Nerve involvement signifies stage T4 disease (see section below). The 
foramen ovale and lacerum are common routes of tumour extension into the intracranial 
cavity (King & Bhatia, 2010). While the skull base foramina present an unobstructed route 
for tumor spread, direct invasion of the bone bordering these foramina is also a common 
finding. The skull base foramina are best assessed on coronal images. Less common findings 
include inferior spread of tumor to involve the hypoglossal nerve canal (XII nerve) and 
jugular foramen (IX-XI nerves) (King & Bhatia, 2010).  
It is important to differentiate tumour spread into the paranasal sinuses – which include 
the ethmoid sinuses, sphenoid sinuses, and maxillary sinuses – from benign mucosal 
inflammatory changes, which are common in patients with NPC. On MRI, mucosal 
thickening can be distinguished from NPC by a greater uniform T2-weighted signal and a 
marked degree of contrast enhancement. With tumor invasion into the ethmoid sinuses, 
which usually occurs via direct spread from the sphenoid sinus or nasal cavity, there is a 
reduced chance of shielding the optic nerve from the radiation dose in RT. Involvement of 
the sphenoid sinus, which is separated from the nasopharynx by only a thin plate of bone, 
is a common finding (Figure 11). In contrast, anteroinferior tumour invasion into the 
maxillary sinuses is a rare event, except in late disease where there is usually extensive 
invasion throughout the nasal cavity, other paranasal sinuses, skull base, and brain (King 
et al., 1999). Sinus involvement is seen on imaging as a loss of contiguity of the sinus 
walls. 
7.4 T4 NPC 
T4 disease is denoted by intracranial extension and/or involvement of the cranial nerves, 
hypopharynx, orbit, or masticator space. Unchecked, NPC can extend superiorly into the 
cavernous sinus and dura (Figure 12), while direct invasion of the brain is rare at 
diagnosis (King & Bhatia, 2010). There are multiple routes into the cavernous sinus, 
including extension from tumour surrounding the horizontal portion of the internal 
carotid artery or cranial nerve V3, as well as extension from the orbital fissures or the 
skull base in the region of the foramen ovale or sphenoid sinus (King & Bhatia, 2010). 
Within the cavernous sinus, cranial nerves III, IV, V1, V2, and VI are vulnerable to tumour 
invasion. Their involvement is manifested clinically through an abnormal neurological 
examination, as well as by signs and symptoms of various cranial nerve palsies, including 
extraocular muscle dysfunction, facial pain, paresthesia and numbness. True perineural 
spread, however, is uncommon in the pre-treatment setting (King & Bhatia, 2010). 
Prognostically, cranial nerve involvement has been shown to be associated with a higher 
rate of distant metastases and decreased survival (Yu et al., 2010). Radiologically, post-
contrast T1-weighted MR sequences with fat saturation are used to assess for cranial 
nerve involvement, especially for V2 along foramen rotundum (Figure 13) and V3 in the 
foramen ovale (Figure 14). Contrast-enhanced MRI shows perineural disease extension 
and cavernous sinus involvement as asymmetric nodular thickening and abnormal 
enhancement. Skip lesions may also be noted. A late sequelae is expansion of the bony 
canals in which these nerves travel. 
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Fig. 12. Coronal postcontrast study shows a large NPC that has extended laterally into the 
right masticator space as well as superiorly to invade the cavernous sinus, sphenoid sinus 
and cause mass effect upon the right temporal lobe.  
 
Fig. 13. Axial image shows asymmetric thickening and enhancement along the left V2 nerve 
(arrows). 
Orbital invasion, usually arising from the pterygopalatine fossa via the inferior orbital 
fissure or directly from the cavernous sinus, denotes the most extensive form of disease 
(King & Bhatia, 2010) (Figure 15). From the PPS, pterygoid base, or pterygomaxillary fissure, 
NPC can extend laterally to involve masticator space, which includes the medial and lateral 
pterygoid muscles, temporalis muscle, infratemporal fat, as well as the mandibular division 
(V3) of the trigeminal nerve (Figure 14). Disease involving the masticator space can give rise 
to trismus and weakness in mastication. In addition, the V3 nerve is vulnerable to tumour 
infiltration within the masticator space. Both antegrade and retrograde perineural spread 
along V3 is possible. From the masticator space, NPC can also extend superiorly through the 
floor of the middle cranial fossa and foramen ovale to gain access to the intracranial cavity 
and the cavernous sinus. 
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Fig. 14. Coronal image shows NPC that has extended laterally into the left masticator space 
and subsequent perineural tumor tracking superiorly (dashed arrows) along V3 into the left 
cavernous sinus (*). Solid arrow shows the normal contralateral V3 nerve. 
 
Fig. 15. Axial T2 weighted scan shows intermediate signal tumor that has extended through 
the superior orbital fissure into the left orbit. 
The hypopharynx, which is the most inferior site included in the TMN staging classification, 
is very rarely involved at diagnosis due to the tendency of NPC to extend superiorly rather 
than inferiorly (King & Bhatia, 2010).  
7.5 Nodal stage 
The NPC N classification system differs from other head and neck mucosal malignancies 
(see Box 1). Up to 60–90% of NPC patients will have nodal metastases at presentation 
(Glastonbury, 2007; Goh & Lim, 2009), suggesting that only 10-40% of cases present 
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without positive nodal disease (N0). Positive neck nodal disease in NPC is associated with 
an increased risk of local recurrence and distant metastases (Goh & Lim, 2009). Unlike 
other head and neck squamous cell carcinomas, nodal disease in NPC is more frequently 
bilateral. 
NPC generally follows a very orderly pathway of nodal spread, beginning with the (lateral) 
retropharyngeal lymph nodes (RPN) (Figure 16) – located medial to the carotid artery – 
before involving nodal groups along the internal jugular chain (level II to IV), spinal 
accessory chain (Va and Vb), as well as supraclavicular nodes (Glastonbury, 2007; King et al., 
2004). Level IIa or b nodes, located posterior to the jugular vein in the upper neck, are the 
most common site for non-retropharyngeal node involvement (Mao et al., 2008) (Figure 17).  
 
Fig. 16. Cystic right retropharyngeal lymph node. 
 
Fig. 17. Right sided level II adenopathy (*). 
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Nodal disease in the submandibular and parotid/periparotid regions is a rare occurrence 
(Chong & Fan, 2000; King & Bhatia, 2010), but should be evaluated for radiotherapy 
planning purposes. Although the RPN are generally considered the first echelon of 
metastatic spread, studies have shown that this is not true in all cases (Liu et al., 2006; Mao et 
al., 2008; Ng et al., 2004; Wang et al., 2009). While King et al. found that the RPN were 
bypassed in only 6% of cases to preferentially affect the level II distribution, Ng et al. found 
that 17 of 89 cases of NPC bypassed the RPN (King et al., 2000; Ng et al., 2004). In addition, 
Ng et al. also reported skip metastases in the lower neck lymph nodes and the 
supraclavicular fossa in 7.9% of cases, and distant metastases to thoracic and abdominal 
nodes in 3-5% of cases. After radiotherapy, level I nodes may also become involved (Ahuja 
et al., 1999). 
In the current N classification system, N1 disease consists of the presence of unilateral 
metastasis in cervical lymph node(s) that are 6 cm or less in their greatest dimension, and/or 
unilateral or bilateral RPN metastasis that are 6 cm or less in their greatest dimension. 
Nodes greater than 3 cm in size are generally considered “nodal masses” and are indicative 
of confluent nodes. N2 disease is defined by bilateral metastasis in the cervical lymph 
node(s) that are again 6 cm or less in greatest dimension. Unlike other carcinomas in the 
neck, N2 is not further divided into substages. In both N1 and N2 stages, disease is 
restricted to above the supraclavicular fossa. Once supraclavicular fossa nodal involvement 
is noted, the disease is upstaged to N3b. Supraclavicular nodes include all lymph nodes seen 
on the same axial cross-sectional slice as a portion of the clavicle, and include Level IV and 
Vb nodes. Stage N3a disease is defined by matted nodes greater than 6 cm in their greatest 
dimension, although this is a rare finding (King & Bhatia, 2010) (Figure 18).  
 
Fig. 18. Massive conglomerate right sided neck adenopathy measuring over 6cm in 
dimension -N3a disease. 
While distinguishing between the primary tumour mass and adjacent RPN is best assessed 
with MRI, cervical lymph nodes can be evaluated accurately with both MRI and CT (King et 
al., 2004). T2-weighted imaging with fat saturation shows nodes as bright structures in the 
posterior cervical fat (Figure 17). The higher resolution of CT facilitates the visualization of 
neck adenopathy, as well as nodal necrosis and extracapsular extension. The latter manifests 
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as a loss or irregularity of the nodal margins, and/or streakiness of the adjacent fat (Yu et al., 
2010). Patients with nodes showing necrosis and extranodal spread have a very poor 
prognosis with a 50% decreased 5-year survival rate (Som et al., 1987).  
There are several features on imaging that are suggestive of metastatic nodal disease, 
including a large size (although there is no accepted size criterion, generally >1.5 cm for 
levels I and II, >1 cm for levels for levels IV-VII, and >5 mm for RPN using the shortest 
transaxial diameter is considered suspicious) (Goh & Lim, 2009; King & Bhatia, 2010), a 
group of 3 or more nodes borderline in size, rounded nodes with loss of the fatty hilum, and 
necrosis (King & Bhatia, 2010). If identified, necrosis is considered 100% specific. However, 
due to resolution restrictions, necrosis can only be reliability identified in tumour foci 
greater than 3 mm, of which approximately one-third reportedly have nodal necrosis (Goh 
& Lim, 2009; Som & Brandwein, 2003; Yousem et al., 1992). Necrosis or cystic change is 
hypointense on T1-weighted images with rim enhancement with contrast, and hyperintense 
on T2-weighted images (Figure 16). In CT images, necrosis is seen as a focal area of 
hypoattenuation with or without rim enhancement (Figure 19). 
 
Fig. 19. Bilateral level II adenopathy. Focal areas of lower attenuation on CT is compatible 
with the presence of necrotic change.  
7.6 Distant metastasis (M) 
The M stage of NPC is similar to that of other malignancies, whereby M0 signifies the 
absence of distant metastasis and M1 refers to the presence of such disease. NPC has the 
highest incidence of distant metastasis among head and neck cancers, with a rate as high as 
11% at diagnosis (Kumar et al., 2004; Teo et al., 1996). The likelihood of metastasis increases 
with increasing T and N stage. 
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The most commonly affected regions are the bone, lung and liver (Chiesa & De Paoli, 2001) 
(Figure 20). Thus, bones and lung apices should be evaluated for tumour involvement in 
head and neck MRI studies, especially in patients with risk factors such as metastatic 
cervical nodes which extend to the supraclavicular fossa (stage N3b). 
 
Fig. 20. A and B 20A is a sagittal T1 weighted exam of the spine showing multiple areas of 
abnormal intermediate signal within vertebral bodies in the lower thoracic and lumbar 
spine -bony metastases. 20B is a contrast CT of the abdomen that shows the presence of 
multiple liver metastases. 
The presence of M1 disease is associated with shorter survival rates (Teo et al., 1996) and 
significantly alters patient management, as such patients are generally considered to be 
incurable. Median survival is under four months and approximately 90% of patients with 
distant metastases pass away within a year (Goh & Lim, 2009; Khor et al., 1978). The goal of 
treatment in such instances will be palliation with therapy being applied for locoregional 
symptom control. 
The exact method for the evaluation of distant metastasis will vary from institution to 
institution. Imaging options include bone scintigraphy, chest x-ray, CT of the thorax, 
abdomen and pelvis, and PET/CT. Studies have shown fluorodeoxyglucose PET/CT 
imaging to have a higher sensitivity and specificity in detecting distant metastases (Chen et 
al., 2006; Chua et al., 2009; Comoretto et al., 2008; King et al., 2008; Lin et al., 2008; Liu et al., 
2007; Ng et al., 2009; Wang et al., 2007; Yu et al., 2010). 
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8. Tumour volume 
Tumour volume has also been reported to have significant prognostic relevance outside of 
the TNM classification system (Wei & Sham, 2005). There is an estimated 1% increase risk of 
local control failure with every 1 cm3 increase in tumour volume. The increased risk is 
attributed to factors such as increase number of tumour clonogens, tumor hypoxia and 
relative radioresistance, etc (Bentzen et al., 1991; Johnston et al., 1995; Lartigau et al., 1993; Sze 
et al., 2004). However, issues with standardized methods of volume measurement, the intra- 
and interobserver reliability due to operator-dependent tracing, as well as the technical 
challenges associated with implementing this in the clinical setting – including the time it 
takes to perform this tedious task – have prevented it from being routinely used in daily 
practice. 
9. Summary 
Nasopharyngeal carcinoma is a relatively rare neoplasm with a characteristic geographic 
and ethnic distribution. It most commonly arises in the lateral pharyngeal recess, and has a 
tendency to invade widely and metastasize. Cervical lymphadenopathy is very common at 
presentation and is a common presenting complaint.  
Diagnosis of NPC can be made on endoscopically-guided biopsy, but effective treatment of 
NPC requires an accurate mapping of tumor volume and extent with imaging. Imaging 
allows for evaluation of tumour extent, including submucosal, osseous, and intracranial 
tumour spread which cannot be assessed clinically or endoscopically. Staging of NPC is 
based on the new 2010 AJCC guidelines. MRI is the best tool for assessing tumour extent 
under the current staging system, while high-resolution CT has value for assessing cortical 
bone erosion and PET/CT is emerging as the most accurate modality for assessing distant 
metastases and recurrence. 
A thorough understanding of the anatomy of the nasopharynx and surrounding structures, 
as well as the natural history of the disease and patterns of spread, allows for accurate 
tumour mapping and treatment planning. 
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